Vivian Laquer

1.2k total citations
37 papers, 392 citations indexed

About

Vivian Laquer is a scholar working on Dermatology, Immunology and Allergy and Immunology. According to data from OpenAlex, Vivian Laquer has authored 37 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Dermatology, 13 papers in Immunology and Allergy and 8 papers in Immunology. Recurrent topics in Vivian Laquer's work include Dermatology and Skin Diseases (22 papers), Allergic Rhinitis and Sensitization (8 papers) and Food Allergy and Anaphylaxis Research (7 papers). Vivian Laquer is often cited by papers focused on Dermatology and Skin Diseases (22 papers), Allergic Rhinitis and Sensitization (8 papers) and Food Allergy and Anaphylaxis Research (7 papers). Vivian Laquer collaborates with scholars based in United States, Germany and Canada. Vivian Laquer's co-authors include Kristen M. Kelly, Andreas Wollenberg, Sady Alpizar, Christophe Piketty, Melinda Gooderham, John Browning, Chitra R Natalie, Pedro Herranz, Nina Magnolo and Deborah Keefe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Journal of Investigative Dermatology.

In The Last Decade

Vivian Laquer

29 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vivian Laquer United States 12 268 154 98 92 66 37 392
Atsuko Fukuyasu Japan 10 190 0.7× 103 0.7× 74 0.8× 86 0.9× 77 1.2× 32 309
Saki Fukaya Japan 9 160 0.6× 94 0.6× 74 0.8× 72 0.8× 69 1.0× 31 277
Line Raaby Denmark 9 117 0.4× 41 0.3× 234 2.4× 50 0.5× 52 0.8× 15 344
Nathalie Gunera-Saad France 6 69 0.3× 67 0.4× 114 1.2× 83 0.9× 28 0.4× 7 304
Mikako AOKI Japan 9 65 0.2× 53 0.3× 103 1.1× 87 0.9× 45 0.7× 27 294
Teresa Gonzalez‐Quevedo Spain 11 43 0.2× 70 0.5× 105 1.1× 104 1.1× 40 0.6× 21 453
Inoncent Agueusop Germany 8 108 0.4× 70 0.5× 72 0.7× 40 0.4× 43 0.7× 15 311
Stefan Woehrl Switzerland 2 77 0.3× 58 0.4× 109 1.1× 12 0.1× 52 0.8× 2 230
Hanna Bonnekoh Germany 12 101 0.4× 36 0.2× 136 1.4× 246 2.7× 26 0.4× 34 404

Countries citing papers authored by Vivian Laquer

Since Specialization
Citations

This map shows the geographic impact of Vivian Laquer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivian Laquer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivian Laquer more than expected).

Fields of papers citing papers by Vivian Laquer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivian Laquer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivian Laquer. The network helps show where Vivian Laquer may publish in the future.

Co-authorship network of co-authors of Vivian Laquer

This figure shows the co-authorship network connecting the top 25 collaborators of Vivian Laquer. A scholar is included among the top collaborators of Vivian Laquer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivian Laquer. Vivian Laquer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thaçi, Diamant, Vivian Laquer, Charles Lynde, et al.. (2025). Targeting IL-22RA1 with temtokibart: A novel approach in atopic dermatitis: Phase 2a monotherapy study results. Journal of Allergy and Clinical Immunology. 157(3). 666–676.
2.
Alexis, Andrew, Jill Waibel, Paul F. Wallace, et al.. (2025). Lebrikizumab Improves Atopic Dermatitis in Adult and Adolescent Patients With Skin of Color: 16-Week Results From the ADmirable Study. SKIN The Journal of Cutaneous Medicine. 9(1). s515–s515.
3.
Alexis, Andrew, Jill Waibel, Paul F. Wallace, et al.. (2025). Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable Study. American Journal of Clinical Dermatology. 26(5). 803–817. 1 indexed citations
4.
Forman, Seth, Dipak Patel, Alexa B. Kimball, et al.. (2025). A randomized, double-blind, placebo-controlled phase 2 study of eltrekibart, a novel septa-specific monoclonal antibody to CXCR1/2 ligands, in adults with hidradenitis suppurativa. Journal of the American Academy of Dermatology. 94(2). 530–538.
5.
Stein‐Gold, Linda, Diamant Thaçi, Andrew Pink, et al.. (2024). 733 - Nemolizumab elicits fast itch response in atopic dermatitis within 2 days: a post hoc analysis of ARCADIA 1 and 2 data. British Journal of Dermatology. 191(Supplement_2).
6.
7.
Soung, Jennifer, Vivian Laquer, Joseph F. Merola, et al.. (2024). The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis. Dermatology and Therapy. 14(8). 2181–2193. 3 indexed citations
8.
Blauvelt, Andrew, Barry Ladizinski, Vimal H. Prajapati, et al.. (2023). Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up). Journal of the American Academy of Dermatology. 89(3). 478–485. 23 indexed citations
9.
Soung, Jennifer, Vivian Laquer, Seth Forman, et al.. (2023). LB1702 Lebrikizumab does not impact vaccine-induced immune responses: Results from a phase 3 study in adult patients with moderate-to-severe atopic dermatitis. Journal of Investigative Dermatology. 143(9). B15–B15. 2 indexed citations
10.
Gold, Linda Stein, Diamant Thaçi, Jacob P. Thyssen, et al.. (2023). Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials. American Journal of Clinical Dermatology. 24(4). 595–607. 34 indexed citations
11.
Paller, Amy S., Carsten Flohr, Lawrence F. Eichenfield, et al.. (2023). Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study. Dermatology and Therapy. 13(7). 1517–1534. 26 indexed citations
12.
Sidbury, Robert, Sady Alpizar, Vivian Laquer, et al.. (2022). Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents. Dermatology and Therapy. 12(3). 631–642. 29 indexed citations
13.
Magnolo, Nina, Külli Kingo, Vivian Laquer, et al.. (2021). A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results. Journal of the American Academy of Dermatology. 86(1). 122–130. 28 indexed citations
14.
Juhász, Margit, Vivian Laquer, James H. Jerkins, & Janellen Smith. (2020). “Peeling paint” dermatosis in a leukemia patient. JAAD Case Reports. 6(4). 354–356. 1 indexed citations
15.
Laquer, Vivian, Ryan W. Dellinger, Feng Liu, et al.. (2018). 12-Hydroxyeicosatetraenoic acid levels are increased in actinic keratoses and squamous cell carcinoma. Journal of the American Academy of Dermatology. 79(6). 1152–1153. 4 indexed citations
16.
Desai, Sheetal, et al.. (2015). Efficacy of intravenous immunoglobulin monotherapy in patients with cutaneous lupus erythematosus: results of proof-of-concept study. SHILAP Revista de lepidopterología. 7(1). 5804–5804. 25 indexed citations
17.
Laquer, Vivian, et al.. (2013). Microarray analysis of port wine stains before and after pulsed dye laser treatment. Lasers in Surgery and Medicine. 45(2). 67–75. 16 indexed citations
18.
Laquer, Vivian, et al.. (2012). Immunohistochemistry of angiogenesis mediators before and after pulsed dye laser treatment of angiomas. Lasers in Surgery and Medicine. 44(3). 205–210. 8 indexed citations
19.
Laquer, Vivian, et al.. (2009). Angiogenesis in cutaneous disease: Part I. Journal of the American Academy of Dermatology. 61(6). 921–942. 32 indexed citations
20.
Laquer, Vivian, et al.. (2009). Angiogenesis in cutaneous disease: Part II. Journal of the American Academy of Dermatology. 61(6). 945–958. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atsuko Fukuyasu Breakdown of academic impact, for papers by Saki Fukaya Breakdown of academic impact, for papers by Line Raaby Breakdown of academic impact, for papers by Nathalie Gunera-Saad Breakdown of academic impact, for papers by Mikako AOKI Breakdown of academic impact, for papers by Teresa Gonzalez‐Quevedo Breakdown of academic impact, for papers by Inoncent Agueusop Breakdown of academic impact, for papers by Stefan Woehrl Breakdown of academic impact, for papers by Hanna Bonnekoh
Rankless by CCL
2026